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The authors have studied regularities of adsorption of 99mTc (VII) on the activated gamma-oxide, Al2O3. 
It has been shown that the sorption capacity of the oxide on the radionuclide depends on its acid treat-
ment. Technetium-99m recovery process in the presence of stannous Sn (II) with the aim to determine it is 
necessary and sufficient quantity, that would provide a complete "recovery" of 99mTc in the reaction mixture 
has been investigated. The adsorption process of the restored 99mTs on the nanoscale powder of gamma-
aluminum oxide has been studied, and the method of obtaining nanocolloids 99mTc (IV)-Al2O3 has been de-
veloped. The medical-biological testing of the agents 99mTc (IV) - Al2O3 on test animals for the determina-
tion of the functional suitability for the scintigraphic  imaging of lymph nodes has been carried out. 
 
Keywords: Technetium-99m, Aluminum Oxide, Active Centers, Molybdenum, Adsorption, Nanocolloid 
Labeled Technetium-99m 
 
  PACS number: 82.70.Dd 
 
 
1. INTRODUCTION 
 
In the world practice nanocolloid preparations la-
beled with a short-lived radionuclide technetium-99m 
(99mTc) are widely used for diagnostic tests in oncology, 
cardiology, for the detection of inflammatory diseases of 
the musculoskeletal system, cirrhosis, hepatitis and 
other diseases. 
The use of radioactive nanocolloids in oncology is 
based on the possibility of the rapid and effective iden-
tification of "sentinel" lymph nodes (SLN), which are 
the first lymph nodes where the lymph from a malig-
nant tumor flows. These nodes, by filtering the afferent 
lymph, become a "trap" for malignant cells, so their 
biopsy is an objective diagnostic criterion for distrib-
uting a malignant process. The optimal effective meth-
od of identifying areas of localization of SLN is scintig-
raphy or radiometry with using technetium-99m-
labeled nanocolloids [1]. 
As a rule, nanocolloid preparations are made on the 
basis of compounds forming stable hydrosols. The deci-
sive factor for the success is not so much their chemical 
composition as the size of the nanoparticles. It is 
known that the optimum particle size for lymphoscin-
tigraphy is 20-100 nm. Such particles are derived from 
tissues at a rate which does not allow them to pene-
trate into the bloodstream. On the other hand, particles 
with sizes less than 20 nm can easily pass into the 
bloodstream, which prevents the imaging of lymph 
nodes [2]. 
Most of the known nanokolloid radiopharmaceuti-
cals represent simple inorganic complexes of 99mTc with 
rhenium sulfide and antimony, obtained by a compli-
cated technology. However, we have carried out prelim-
inary studies which showed that stable colloidal com-
pounds could be obtained in simpler way - by means of 
adsorption of the reduced 99mTc on the alumina gamma 
[3]. The original premise for the use of alumina as a 
"carrier" label of 99mTc is its relatively low toxicity, 
combined with good adsorption properties, availability 
and low cost. However, the research on obtaining 99mTc 
labeled nanocolloids on the basis of gamma-Al2O3 oxide 
has been conducted by anybody to date. This has de-
termined the purpose of our work. 
 
2. METHODS OF SAMPLE PRODUCTION AND 
ANALYSIS 
 
As the object of these studies was used the na-
nopowder with low-temperature (cubic) modification of 
the gamma-oxide Al2O3. The specific surface area of the 
was 320 m2/g. According to electron microscopy, the 
particles were irregular in shape and had a non-smooth 
surface. Their average length was in the range of 8-10 
nm with the diameter of 2 nm. For the experiments, the 
original suspension of aluminum oxide was prepared by 
diluting the sample of about 5 mg of gamma-Al2O3 ox-
ide nanopowder with the 7-10 nm particles diameter in 
10 ml of water. To prevent the partial loss of oxide in 
the sediment a further processing of the suspension in 
an ultrasonic bath was carried out, after which the  
activation of the surface of the gamma - oxide 0.05 M 
HCl was brought up to pH = 2. The adsorption process 
was carried out under static conditions by mixing 2 ml 
of the suspension with 2 ml of the eluate followed by 
injecting Sn (II) with the rate of 0.0175 mg/ml. 
Determining the amount of technetium-99m-labeled 
nanocolloidal particles was carried out by the methods 
based on measuring the activity of the suspension be-
fore and after filtration through filters with desired 
pore sizes: 220, 100 and 50 nm. For this purpose, three 
samples were chosen with the at 3 volume of 5 ml of the 
original solutions and filtrates for  the subsequent 
measurement of their activity, as well as samples-for 
chromatograms for evaluating the content of impurities 
in the filtrates of unreacted 99mTc (VII) in the tested 
product. Calculations of the yield of products with dif-
ferent particle sizes were determined using the follow-
ing formulas: 
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where Aис – the activity of the original suspension be-
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fore the filtration, A1 – the activity measured after the 
filtration through the filter of 220 nm, A2 – the activity 
after the filtration through 100 nm, A3 – the activity 
after the filtration through 50 nm. 
The determination of the radiochemical purity of 
obtained nanocolloidal preparations were carried out by 
the thin – layer chromatography. The scanning of the 
chromatograms was carried out on the facility"Gamma-
Scan-01A." On the computer screen was received the 
information about the location of  activity peaks of the 
labeled and free (unreacted) 99mTc compounds.  
For the original of the production of the preparation 
99mTc (eluate) was used the chromatographic generator 
"99mTc-GT-TOM" produced by the Institute of Physics 
and Technologies in Tomsk Polytechnic University. 
 
3. RESULTS AND DISCUSSION 
 
Before the adsorption of various anions on the oxide 
Al2O3 its acid activation is previously carried out  in or-
der to create stable adsorption centers on the surface. In 
this context, at the first phase were found optimal condi-
tions for acid treatment, which would provide the maxi-
mum amount of adsorption of the radionuclide. 
Then the adsorption characteristics of aluminum ox-
ide for different amounts of absorbed hydrochloric acid 
was studied. The change of the sorption capacity of alu-
minum oxide depending upon the amount of absorbed 
acid are shown in Fig. 1. 
 
 
 
Table 1 – Appointment of special paragraph styles 
 
Fig. 1 – The change of sorption capacity of aluminum oxide 
depending upon the amount of absorbed acid. 
 
Abstract is an essential part of the article metadata. 
One should always remember that the main purpose of 
the abstract is to attract the target reader. Abstract 
passed to the abstract database, where the automatic 
search widely used.  
The structure of this part of the text should be as 
simple as possible, namely, one (sometimes two) para-
graphs of a total of 100-200 words. Authors should avoid 
the equations, symbolic notations, obscure acronyms, 
because they complicate the understanding and automat-
ic search. Style to format is «NAP_Abstract». 
From this relation we see that the maximum adsorp-
tion is more than 30 % of the introduced  radionuclide 
activity, being observed in the oxide with the absorbed  
mass of 2·10 – 4 mol/g. 
However, using the data obtained, it follows that 
99mTc, which is present in the original eluate to with the 
highest degree of oxidation of (VII), does not have a high 
sorption capacity. Therefore, we have carried out a study 
on the adsorption of reduced technetium-99m, which is 
known to be  chemically more active in the lower oxida-
tion state. For restoring 99mTc (VII), present in the origi-
nal eluate 99mTc, tin chloride dihydrate (II) (SnCl2 ∙ 2H2O) 
was used. 
Therefore, preliminary studies were carried out to es-
tablish the necessary and enough amount of Sn (II), 
which provides the complete recovery of 99mTc (VII) in the 
eluate from the 99Mo/99mTc-generator. The results are 
shown in  
 
Table 1 – Changing the content of 99mTc (VII) in the eluate 
from the 99Mo/99mTc-generator depending on the concentration 
of tin (II). 
 
Concentration 
(Sn(II)), mg/ml 
Tc(VII), % 
0.14 0 
0.105 0 
0.07 0.7 
0.035 3 
0.0175 7 
0.00875 10 
 
They imply thatot the optimal amount of Sn (II) in the 
reaction mixture, which ensures the content of 99mTc (VII) 
at less then 10 %, corresponds a value ranging from 
0.00875 to 0.0175 mg/ml. 
In order to avoid the hydrolysis of tin, which leads to 
its oxidation and reduction of it restoring properties, in 
the future, for preparing a nanocolloid solution, instead of 
the solution of tin, we are planning to try its medical 
counterpart - the lyophilizate. 
For the investigation, the initial aluminum oxide 
nanocolloids was prepared by dissolving about 5 mg of 
gamma-Al2O3 oxide nanopowder with the particle diame-
ter of 7-10 nm in 10 ml of water. As a part of the oxide 
was precipitating, in addition to the process the suspen-
sion was treated in an ultrasonic bath until there was no 
more visible residue. For the subsequent activation of the 
gamma-oxide surface was carried out its acid treatment, 
by adding of 0.05 M HCl to pH = 2 in the bottle. For eval-
uating the radiochemical yield of fractions with a given 
diameter of the particles the filtration of the product 
through filters with a pore diameter of 220, 100 and 
50 nm was performed. 
The experiment was conducted using the following 
program. A prepared solution of aluminum oxide nanocol-
loids with 2 ml volume, were added 2 ml of prereduced 
technetium-99m (the introduced in the radiopharmaceu-
ticals (RPC) concentration of tin (II) was CSn = 0.0175 mg 
/ ml). After mixing, the mixture was handled in an ultra-
sonic bath for 10 min. The subsequent filtration of the 
product through the filter of 220 nm showed that all of 
99mTc-labeled colloid (IV) – Al2O3 had the a size of more 
than 220 nm. The content of  the impurity of  unreduced 
99mTc (VII) in the filtrate increased from 5 % (original 
mix) to 56 % due to the fact that 99mTc (VII) adsorbs poor-
ly on the oxide and freely passes through the filter. 
We have preliminary studied the effect of tempera-
ture on the magnitude of nanocolloids and the radiochem-
ical purity of the drug which has shown that the optimum 
temperature regime of the introducing a radiolabel is in 
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the range from 70 to 80  C at 30  min heating. 
The first attempt to influence the size of the particles 
formed in the reaction mixture, was holding a "competi-
tive" interaction reaction of 99mTc (VII) simultaneously 
with aluminum oxide and the reducing agent Sn (II). To 
initiate the reaction was used heating the mixture, as 
well as the introducing the  additives of ascorbic acid and 
gelatin into the reaction mixture. 
Then in the first bottle was added 10 ml of freshly 
prepared solution of Sn (II) with the concentration of 
CSn = 0.0175 mg/ml. 
In the second bottle, at first was add 100 µkl of ascor-
bic acid concentration of 10 mg/ml, followed by 10 ml of 
Sn (II) with the same concentration. 
The third bottle was sequentially added 100 µkl of 
ascorbic acid, 10 ml of solution of tin (II) with the same 
concentration, and after that 100 ml of 10 % solution of 
gelatin. 
Then all the bottles were heated in a water bath (70-
80  C) for 30 min. After cooling to the room temperature 
in an ultrasonic bath was carried out the filtration of 
products obtained through filters with the pore diameters 
of 220, 100 and 50 nm. The results of these studies are 
shown in Table 2. 
 
Table 2. 
Ingredients of mixture Activity, imp. Contents 99mTc(VII), % Radiopharmaceuticals, % Yield % 
Al2O3+99mTc+Sn(II) 549 963 10 88  
filtrate 200 484 907 15 85 82 
filtrate 100 355 591 8 85 62 
filtrate 50 62 917 54 42 5,9 
Al2O3+99mTc+АК+Sn(II) 424 128 8 92  
After heating  370 179 1 99  
filtrate 200 245 972 3 97 66 
filtrate 100 79 030 4 96 19 
Al2O3+99mTc+АК+Sn(II)+ gelatin 383 569 22 78  
After heating 383 569 7 93  
filtrate 200 309 761 9 91 77 
filtrate 100 288 059 7 93 76 
 
 
 
 
Fig. 2 – The drug  distribution in the body of rat  at the intro-
duction of a suspension [Al2O3 + 99mTc + AK + Sn 
(II) + Gelatin]: a) Immediately after injection, b) 30 minutes 
after injection, c) 60 minutes after injection, d ) 120 minutes 
after injection. The numbers  is indicated: 1 – lymph node, and 
2 – Location of the drug 
From the table it follows that in the absence of chem-
ical additives, the yield of labeled nanocolloids of the size 
less than 100 nm is 62 % for the overall radiochemical 
purity of the product 85 %, while the output of ≤ 50 nm 
colloid - less than 6 %. 
The introduction of ascorbic acid to the reaction mix-
ture has resulted in an increase in the radiochemical 
purity  of the filtrate of 100 nm up to 96 %. 
Medico-biological tests of the colloidal drug on the 
basis of oxide- alumina Al2O3 labeled with 99mTc were 
carried out at the Research Institute of Oncology, SB 
RAMS Tomsk city, on the white line of male rats 
"Wistar" with the mass of 300-350. The animal's body 
scintigram obtained at various time intervals are 
shown in Fig. 2. 
On the scintigrams of 60 and 120 minutes is a clearly 
visible sentinel lymph node, located between the bladder 
and the place of injection. The level of accumulation of the 
drug in the lymph node was 1.63 % of the total introduced 
activity, which is enough for its safe visualization. This 
result corresponds closely to the standard requirements 
for such drugs (0.5 – 1.7 %) and proves the functional 
suitability of our synthesized labeled with technetium-
99m, nanocolloid on the basis of gamma-oxide alumina. 
 
4. CONCLUSION 
 
1. The regularities of the adsorption of 99mTc (VII) 
on activated oxide, gamma-Al2O3 have been studied. It 
has been shown that the sorption capacity of the oxide 
on the radionuclide depends on its acid treatment. It 
has been established that the maximum adsorption of 
99mTc on the oxide is observed at the absorbed amount 
of acid 2·10 – 4 mol/g. 
а
  
b 
c d 
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2. The research process of restoration of 99mTc in the 
presence of stannous Sn (II) have been studied. As a 
result, it has been found that the optimum concentra-
tion of the reducing agent, Sn (II) in the RPC must be 
in the range from 0.00875 to 0.0175 mg/ml. 
3. For the first time the adsorption process of the 
reconstructed 99mTs on the nanoscale powder of gam-
ma-aluminum oxide has been studied. 
4. Medico-biological tests of labeled 99mTs on oxide 
Al2O3 have been carried out on rats in order to study 
their distribution in the organism of the experimental 
animals and determine the functional suitability for 
the scintigraphic imaging of lymph nodes. The level of 
accumulation of the drug in the lymph node is 1.5 % of 
the total introduced activity, which is enough for its 
safe imaging. 
This work has been carried out in the frame of state 
program «Sciense». 
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